Source: France Soir

Belgian study on hydroxychloroquine has just been published, on 8,000 patients, and concludes that hydroxychloroquine reduces mortality by 30%, like the Italian study mentioned in our article of August 4, 2020.

The results are edifying and it is surprising that the Scientific Council, the Ministry of Health and the French media do not talk about it more.

Hydroxychloroquine has shown a decrease in mortality from COVID-19, in a proportion of patients similar to that seen in the Italian study, according to a Belgian national analysis published today in the International Journal of Antimicrobial Agents. 

The study is retrospective and of course has several limitations. However, associated with the Iacoviello study, it is starting to build up an important core of data on a large number of patients. 

The effects of hydroxychloroquine are of course limited because, after decades of HIV / AIDS research, the use of a single drug cannot be considered a definitive solution for an illness caused by an RNA virus. Combinations of drugs are needed. 

In this regard, another study published today by the same journal showed the additive effects of azithromycin to a combination of hydroxychloroquine and an HIV protease inhibitor, thus confirming Raoult’s studies. 

Combinations of hydroxychloroquine and the HIV protease inhibitor lopinavir / r are recommended by Chinese guidelines for COVID-19 treatment but have been largely ignored by Western countries, with the exception of Italy, where this association was first encouraged in the guidelines last February but then discouraged by the Italian drug regulatory agency for rather mysterious reasons. Dr. Savarino will express his thoughts on this subject, as they were first recommended in the guidelines of last February, but then discouraged by the Italian Medicines Regulatory Agency (AIFA) for reasons which remain unexplained to date.



Related:

France Study: Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time

The Coronavirus Is Man Made According to Luc Montagnier the Man Who Discovered HIV

France Soir: Oxford, Recovery and Solidarity – Overdosage in two clinical trials with acts considered criminal?

Screening, hydroxychloroquine… Professor Raoult’s criticisms of the management of the health crisis

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »